2025-2034 Antiemetics And Antinauseants Market Roadmap: Insights for Competitive Advantage

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Antiemetics And Antinauseants Market Size Growth Forecast: What to Expect by 2025?
In recent years, there has been a steady expansion in the size of the antiemetics and antinauseants market. It is anticipated to progress from a value of $8.11 billion in 2024 to $8.45 billion in 2025, with a compound annual growth rate (CAGR) of 4.3%. The expansion in the historical period can be credited to factors such as longstanding branding and competitive market dynamics, past treatment preferences, economic situations, global health events in history, and advancements in medical research and technology.

How Will the Antiemetics And Antinauseants Market Size Evolve and Grow by 2029?
The market for antiemetics and antinauseants is predicted to witness consistent growth in the coming years, swelling to $9.7 billion in 2029 with an annual growth rate of 3.5%. This expected growth in the forecasted period is likely due to factors such as advances in research and development, economic conditions, market competition, industry tendencies, alterations in disease manifestations, and changes in healthcare policies and regulations. Key trends in the forecasted period are an enhanced emphasis on patient experience, modifications in healthcare policies, a lean towards non-invasive treatments from consumers, an increased instance of nausea associated with chemotherapy and pregnancy, and the development of targeted treatments.

View the full report here:
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

What Drivers Are Propelling the Growth of Antiemetics And Antinauseants Market Forward?
The rise in the prevalence of cancer propels the antiemetics and antinauseants market. One of the most recommended treatments for cancer is chemotherapy, which can lead to side effects like chemotherapy-induced nausea and vomiting (CINV). However, antiemetics can prevent CINV in approximately 60%-70% of patients. As an example, The American Cancer Society, a non-profit organization based in the U.S., projected in April 2024 that the country recorded about 609,000 cancer-related deaths and anticipated 1.9 million new cancer cases in 2022. Approximately 620,000 cancer deaths are expected, representing a minor surge in mortality rates in 2024. Therefore, as the incidence of cancer rises, so will the demand for antiemetics and antinauseants, which in turn, will boost market revenue.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

Which Emerging Trends Are Transforming the Antiemetics And Antinauseants Market in 2025?
Key players in the antiemetic and antinauseant industries are focusing on creating innovative products such as ready-to-use injectables, designed to simplify treatments and improve patient ease. These new formulations are engineered to function immediately, cutting down the time and intricacy linked to conventional injectable medicines. For example, in July 2024, US-based Amneal Pharmaceuticals introduced FOCINVEZ, the first-of-its-kind ready-to-use injectable formulation of fosaprepitant, created to alleviate acute and delayed nausea and vomiting caused by highly emetogenic cancer chemotherapy. The product, available in a 150 mg/50 mL vial, devoid of Polysorbate 80, eliminates the need for reconstitution or dilution, enabling straight away administration. FOCINVEZ, endorsed for use in adults and youngsters aged six months and above, has additionally been provided a unique J-Code (J1434) for reimbursement.

What Are the Key Segments in the Antiemetics And Antinauseants Market?
The antiemetics and antinauseants market covered in this report is segmented -

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types
2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types
3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:
1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone
2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant
3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine
4) By Cannabinoids: Dronabinol, Nabilone
5) By Benzodiazepines: Lorazepam, Diazepam
6) By Anticholinergics: Scopolamine, Glycopyrrolate
7) By Steroids: Dexamethasone, Methylprednisolone
8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron
9) By Other Drug Types: Herbal Remedies, Acupressure Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

Who Are the Key Players Shaping the Antiemetics And Antinauseants Market's Competitive Landscape?
Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

What Geographic Markets Are Powering Growth in the Antiemetics And Antinauseants Market?
North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2441

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.